Insider · CIK 0001026505
Thomas B Akin
Files at MFON (MOBIVITY HOLDINGS CORP.). First filing Jan 30, 2025, latest Jan 30, 2025.
Thomas B Akin files SEC Form 4 as director and 10% owner at MFON (MOBIVITY HOLDINGS CORP.). Since Jan 30, 2025, Thomas B Akin has reported 1 open-market buy worth $471k and 0 open-market sells worth $0, the latest filed on Jan 30, 2025.
A track record needs three past buys with six months of prices behind them; Thomas B Akin has 0, so none is measured yet.
The newest scored trade: bought $471k of MFON on Sep 30, 2024, filed Jan 30, 2025, scored 35 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MFON: MOBIVITY HOLDINGS CORP.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | MFONbuy MOBIVITY HOLDINGS CORP. | $471k 1,946,232 shares | +7% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase common stock | +964,593 | $0.23 | $225k | 28,216,553 | Jan 30, 2025 |
| Sep 30, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase common stockindirect: Talkot Fund LP | +44,653 | $0.23 | $10k | 28,261,206 | Jan 30, 2025 |
| Dec 31, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase common stock | +895,530 | $0.25 | $225k | 29,156,736 | Jan 30, 2025 |
| Dec 31, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase common stockindirect: Talkot Fund LP | +41,456 | $0.25 | $10k | 29,198,192 | Jan 30, 2025 |
| Jul 3, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +666,666 | $0.00 | $0 | 11,076,739 | Jan 30, 2025 |
| Jul 29, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +250,000 | $0.00 | $0 | 11,326,739 | Jan 30, 2025 |
| Aug 19, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +833,333 | $0.00 | $0 | 12,160,072 | Jan 30, 2025 |
| Sep 16, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +375,000 | $0.00 | $0 | 12,535,072 | Jan 30, 2025 |
| Oct 28, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +583,333 | $0.00 | $0 | 13,118,405 | Jan 30, 2025 |
| Nov 12, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +416,666 | $0.00 | $0 | 13,535,071 | Jan 30, 2025 |
| Nov 22, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +416,666 | $0.00 | $0 | 13,951,737 | Jan 30, 2025 |
| Dec 4, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +666,666 | $0.00 | $0 | 14,618,403 | Jan 30, 2025 |
| Dec 18, 2024 | MFON MOBIVITY HOLDINGS CORP. | POpen-market purchase warrantderivative | +458,333 | $0.00 | $0 | 15,076,736 | Jan 30, 2025 |
Questions about Thomas B Akin
Answered from the filings on this page, as of the latest one.
Is Thomas B Akin buying or selling?
Not in the last 12 months. Thomas B Akin's latest open-market trade on SEC Form 4 was bought $471k of MFON on Sep 30, 2024.
How did Thomas B Akin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas B Akin has 0.
Where does Thomas B Akin file Form 4?
Thomas B Akin has filed Form 4 at MFON (MOBIVITY HOLDINGS CORP.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.